1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)urea

ID: ALA1213924

PubChem CID: 46919120

Max Phase: Preclinical

Molecular Formula: C24H18ClF3N6O

Molecular Weight: 498.90

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1

Standard InChI:  InChI=1S/C24H18ClF3N6O/c1-14-4-5-17(32-23(35)31-16-6-7-19(25)18(11-16)24(26,27)28)12-21(14)34-22-30-10-8-20(33-22)15-3-2-9-29-13-15/h2-13H,1H3,(H,30,33,34)(H2,31,32,35)

Standard InChI Key:  VZONEKWHHXKRRX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   19.3708  -10.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3750  -11.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9417   -9.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2292   -8.9417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2292   -9.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3708   -9.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6542   -8.9333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5167   -9.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0833   -8.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5167   -8.9250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9458   -8.9208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9542  -10.1708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0875  -10.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6583  -10.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8042   -8.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8000   -9.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6583   -9.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3792  -10.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2333  -10.1583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0833   -7.7167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0917  -11.8000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.3667  -12.2125    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.6625  -11.8042    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.0833   -9.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0875  -10.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5208  -10.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2458  -10.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8042  -10.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3667   -8.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8042  -10.5583    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.8000   -8.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0958   -9.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3708   -8.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6625  -10.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3792   -8.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  7  1  0
  4  3  2  0
  5 11  1  0
  6  9  2  0
  7  6  1  0
  8  4  1  0
  9 16  1  0
 10  5  1  0
 11 17  1  0
 12  3  1  0
 13  1  2  0
 14  1  1  0
 15  8  1  0
 16 10  1  0
 17 14  2  0
 18 25  2  0
 19  5  2  0
 20 31  1  0
 21  2  1  0
 22  2  1  0
 23  2  1  0
 24 13  1  0
 25 28  1  0
 26 27  1  0
 27 12  2  0
 28 16  2  0
 29 24  2  0
 30 13  1  0
 31 15  2  0
 32 15  1  0
 33 35  1  0
 34 18  1  0
 35 32  2  0
 17 29  1  0
 18  6  1  0
 26  8  2  0
 33 20  2  0
M  END

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abl1 Tyrosine-protein kinase ABL (212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.90Molecular Weight (Monoisotopic): 498.1183AlogP: 6.91#Rotatable Bonds: 5
Polar Surface Area: 91.83Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.48CX Basic pKa: 4.26CX LogP: 6.12CX LogD: 6.12
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -1.85

References

1. Dietrich J, Hulme C, Hurley LH..  (2010)  The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec, Nexavar, and BIRB-796.,  18  (15): [PMID:20621496] [10.1016/j.bmc.2010.05.063]

Source